NEW YORK (GenomeWeb) — Through a non-targeted metabolomics study, Swedish researchers and their colleagues uncovered four novel biomarkers for coronary heart disease.

As they reported in PLOS Genetics today, researchers led by Uppsala University's Erik Ingelsson studied the metabolomes of more than 3,600 individuals to find four metabolites associated with disease risk: monoglyceride, sphingomyelin, and two types of lysophosphatidylcholine.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

Nov
27
Sponsored by
Genialis & Roche

While next-generation sequencing (NGS) has driven recent advances in precision oncology research, it often falls short when identifying the molecular mechanisms underlying many malignancies. As a result, alternative NGS-based approaches are needed to identify oncogenic drivers and potential drug targets.